Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
1 - 5 UsersAdd to Basket
Live Chat Live Help Software for Website

Global Cancer Drugs market 2009-2013

Infiniti Research Limited, July 2010, Pages: 22


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

The cancer drugs represent a large potential on the therapeutic market. Cancer is the second leading cause of death worldwide after cardiovascular diseases. According to World Heath Organization (WHO), 12 million cancer deaths are likely to occur worldwide, by 2030. Further, the adoption of unhealthy lifestyles choices such as increased use of tobacco, alcohol, and rise in obesity rate in the underdeveloped and developing countries are important factors for the cause of this disease.

Owing to the growing number of cancer-related diseases, there is an intense interest towards cancer drugs research. Many companies (pharmaceutical and biotechnology) are focusing on developing advanced cancer drugs for targeted therapy. Besides, many domestic companies have also increased their focus on R&D capabilities to develop effective cancer treatment for breast, prostate, colon, and pancreatic cancers. Over the next few years, the market is set to witness launch of advanced cancer drugs and entry of new players. Thus, intensifying competition in this industry in the development and marketing of cancer drugs.

The significant advancements in newer cancer drugs and benefits of effective treatment of various cancers are likely to boost this market. Also, the increasing prevalence of cancer cases and the subsequent need for effective means of treatment offer potential growth opportunity. Further, the enhanced focus on tailored drug delivery in cancer treatment coupled with benefits of molecular biomarkers in drug discovery are likely to support growth in the Cancer Drugs market.

This report highlights the scope of the Global Cancer Drugs market 2009-2013, along with trends, drivers, growth inhibitors and a few major vendors in the market.


Product samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

Global Breast Cancer Drugs market 2009-2013

Global Cardiac Markers market 2009-2013

Anti-cancer Drugs Market in APAC 2011-2015

Global Radiation Oncology Market 2009-2013

Global Cancer Drug Market 2010-2014

Breast Cancer Market Report: 2011 Edition

Global Rheumatoid Arthritis Drugs Market 2011-2015

Anti-cancer Drugs Market in Japan 2011-2015

Prostate Cancer Drug Discoveries: What the Future Holds

Global Epinephrine Market 2011-2015



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds